Priyamvada Acharya studies how proteins on the surface of HIV move to invade cells and evade the immune system. For many years her research has been focused on the HIV-1 envelope (Env), a protein on the HIV-1 surface that the virus uses to enter human cells. In December 2019, she and her colleagues reported promising results of a new strategy that could lead to a long-sought vaccine.
Three months later, when the coronavirus pandemic was declared, the SARS-CoV-2 virus suddenly became an urgent target.
Acharya thought carefully about what her group at the Duke Human Vaccine …Find out More »